Towards precision medicine in migraine: Recent therapeutic advances and potential biomarkers to understand heterogeneity and treatment response

Juhasz, Gabriella ✉ [Juhász, Gabriella (Neurológia), author] Department of Pharmacodynamics (SU / FP); NAP3.0-SE Neuropsychopharmacology Research Group (SU / FP / DP); Gecse, Kinga** [Gecse, Kinga (Farmakológia és I...), author] Department of Pharmacodynamics (SU / FP); NAP3.0-SE Neuropsychopharmacology Research Group (SU / FP / DP); Baksa, Daniel [Baksa, Dániel (pszichológia, gen...), author] Department of Pharmacodynamics (SU / FP); Department of Personality and Clinical Psychology (PPCU / DPszich); NAP3.0-SE Neuropsychopharmacology Research Group (SU / FP / DP)

English Survey paper (Journal Article) Scientific
Published: PHARMACOLOGY & THERAPEUTICS 0163-7258 1879-016X 250 Paper: 108523 , 23 p. 2023
  • SJR Scopus - Pharmacology (medical): D1
Identifiers
Fundings:
  • (2017-1.2.1-NKP-2017-00002.)
  • (National Brain Programme 3.0(NAP2022-I-4/2022))
  • (TKP2021-EGA-25)
  • (2019-2.1.7-ERA-NET-2020-00005) Funder: Nemzeti Kutatási, Fejlesztési és Innovációs Hivatal
  • ERA PerMed(ERAPERMED2019-108)
  • (K 143391)
  • (ÚNKP-22-4-I-SE-10)
  • (ÚNKP-22-3-II-SE-27)
Subjects:
  • Pharmacology, pharmacogenomics, drug discovery and design, drug therapy
Citation styles: IEEEACMAPAChicagoHarvardCSLCopyPrint
2025-04-04 17:40